REVIEW
Add like
Add dislike
Add to saved papers

[Diabetic metabolic emergencies].

Orvosi Hetilap 2005 March 7
Diabetic ketoacidosis and hyperglycaemic hyperosmolar syndrome are two acute complications of diabetes that may result in high mortality. Effective standardized treatment protocols, as well as prompt identification and treatment of the precipitating cause, are important factors affecting outcome. The authors review the pathomechanism, clinical features, complications and current recommendations for management of ketoacidosis and hyperglycaemic hyperosmolar syndrome. In patients with type 2 diabetes may develop anaerobic (type A) lactic acidosis from tissue hypoxia, while aerobic (type B) lactic acidosis is a rare complication of biguanide therapy if contraindications to metformin are observed. Mortality remains very high, especially when serious comorbidities are present. Hypoglycaemia is a major factor preventing patients with both type 1 and type 2 diabetes from achieving near-normal plasma glucose targets. The authors summarize clinical presentation and therapeutic possibilities of hypoglycaemia on the basis of the literature.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app